disulfiram has been researched along with np 031112 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 5 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bai, F; Deng, Y; Du, X; Duan, Y; Guddat, LW; Jiang, H; Jiang, R; Jin, Z; Li, X; Liu, F; Liu, H; Liu, M; Liu, X; Peng, C; Qin, C; Rao, Z; Shi, Z; Wang, L; Xiao, G; Xu, W; Xu, Y; Yang, H; Yang, K; Yang, X; You, T; Yu, J; Zhang, B; Zhang, L; Zhao, Y | 1 |
Alonso, C; Barrado-Gil, L; Campillo, NE; Cuesta-Geijo, MÁ; Gil, C; Ginex, T; Maestro, I; Martinez, A; Nozal, V; Ramírez, D; Urquiza, J | 1 |
Easwaran, M; Manickam, M; Pillaiyar, T; Wendt, LL | 1 |
Amin, SA; Banerjee, S; Gayen, S; Ghosh, K; Jha, T | 1 |
Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
3 review(s) available for disulfiram and np 031112
Article | Year |
---|---|
COVID-19: Drug Targets and Potential Treatments.
Topics: Amino Acid Sequence; Animals; Antiviral Agents; COVID-19 Drug Treatment; Drug Repositioning; Enzyme Inhibitors; Humans; Immunity, Innate; SARS-CoV-2 | 2020 |
The recent outbreaks of human coronaviruses: A medicinal chemistry perspective.
Topics: Antiviral Agents; Chemistry, Pharmaceutical; COVID-19; Disease Outbreaks; Drug Repositioning; Humans; Virus Internalization | 2021 |
Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors.
Topics: Antiviral Agents; Catalytic Domain; Coronavirus 3C Proteases; Cysteine Proteinase Inhibitors; Drug Discovery; Drug Evaluation, Preclinical; Molecular Docking Simulation; Molecular Structure; Protein Binding; Quantitative Structure-Activity Relationship; SARS-CoV-2 | 2021 |
2 other study(ies) available for disulfiram and np 031112
Article | Year |
---|---|
Structure of M
Topics: Antiviral Agents; Betacoronavirus; Cells, Cultured; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; Cysteine Endopeptidases; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; Humans; Models, Molecular; Pandemics; Pneumonia, Viral; Protease Inhibitors; Protein Structure, Tertiary; SARS-CoV-2; Viral Nonstructural Proteins | 2020 |
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |